Reply to "Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays".
作者信息
Bounaadja Lotfi, Piret Jocelyne, Goyette Nathalie, Boivin Guy
出版信息
J Clin Microbiol. 2013 Jun;51(6):2014. doi: 10.1128/JCM.00545-13.
Abstract
摘要
相似文献
1
Reply to "Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays".对“通过基于实时PCR的检测方法正确测定爱泼斯坦-巴尔病毒、人类疱疹病毒6型（HHV-6）和HHV-8抗病毒药物敏感性的校准技术”的回复
J Clin Microbiol. 2013 Jun;51(6):2014. doi: 10.1128/JCM.00545-13.
2
Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.通过基于实时聚合酶链反应的检测方法正确测定爱泼斯坦-巴尔病毒、人类疱疹病毒6型（HHV-6）和HHV-8抗病毒药物敏感性的校准技术。
J Clin Microbiol. 2013 Jun;51(6):2013. doi: 10.1128/JCM.00504-13.
3
Evaluation of Epstein-Barr virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.应用基于实时 PCR 的检测方法评估 Epstein-Barr 病毒、人类疱疹病毒 6（HHV-6）和 HHV-8 抗病毒药物敏感性。
J Clin Microbiol. 2013 Apr;51(4):1244-6. doi: 10.1128/JCM.03234-12. Epub 2013 Jan 16.
4
Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.利用流式细胞术测定针对嗜淋巴细胞疱疹病毒的抗病毒效力。
Antiviral Res. 2003 Apr;58(2):149-57. doi: 10.1016/s0166-3542(02)00210-3.
5
Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.通过定量实时聚合酶链反应分析评估对人类疱疹病毒8型（HHV-8）和爱泼斯坦-巴尔病毒（EBV）的抗病毒活性。
Antiviral Res. 2004 Jun;62(3):121-3. doi: 10.1016/j.antiviral.2003.12.005.
6
Efficacy of methylenecyclopropane analogs of nucleosides against herpesvirus replication in vitro.核苷的亚甲基环丙烷类似物在体外抗疱疹病毒复制的功效。
Nucleosides Nucleotides Nucleic Acids. 2003 Dec;22(12):2105-19. doi: 10.1081/ncn-120026633.
7
Real-time PCR determination of human herpesvirus 6 antiviral drug susceptibility.人疱疹病毒6型抗病毒药物敏感性的实时聚合酶链反应测定
J Virol Methods. 2007 Mar;140(1-2):25-31. doi: 10.1016/j.jviromet.2006.10.009. Epub 2006 Dec 6.
8
In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.苯并咪唑D-和L-核糖核苷对疱疹病毒的体外活性。
Antimicrob Agents Chemother. 2003 Jul;47(7):2186-92. doi: 10.1128/AAC.47.7.2186-2192.2003.
9
Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.对人疱疹病毒6型（HHV-6）和EB病毒（EBV）抗体滴度升高且出现包括长期疲劳在内的中枢神经系统功能障碍的患者使用缬更昔洛韦。
J Clin Virol. 2006 Dec;37 Suppl 1:S33-8. doi: 10.1016/S1386-6532(06)70009-9.
10
Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells.抗病毒化合物在人疱疹病毒6感染的神经胶质细胞中的疗效。
J Neurovirol. 2006 Aug;12(4):284-93. doi: 10.1080/13550280600880772.
本文引用的文献
1
Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.通过基于实时聚合酶链反应的检测方法正确测定爱泼斯坦-巴尔病毒、人类疱疹病毒6型（HHV-6）和HHV-8抗病毒药物敏感性的校准技术。
J Clin Microbiol. 2013 Jun;51(6):2013. doi: 10.1128/JCM.00504-13.
2
Evaluation of Epstein-Barr virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.应用基于实时 PCR 的检测方法评估 Epstein-Barr 病毒、人类疱疹病毒 6（HHV-6）和 HHV-8 抗病毒药物敏感性。
J Clin Microbiol. 2013 Apr;51(4):1244-6. doi: 10.1128/JCM.03234-12. Epub 2013 Jan 16.
3
Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.用于评估抗病毒药物对爱泼斯坦-巴尔病毒复制及EBV晚期mRNA表达影响的实时定量PCR
J Virol Methods. 2007 Jul;143(1):38-44. doi: 10.1016/j.jviromet.2007.02.005. Epub 2007 Mar 19.
4
Human herpesvirus 6: a clinical update.人疱疹病毒6型：临床最新进展
Herpes. 2006 May;13(1):20-4.
5
Real-time PCR as a versatile tool for investigating the susceptibility of human herpesvirus 6 to antiviral agents.实时聚合酶链反应作为研究人疱疹病毒6对抗病毒药物敏感性的通用工具。
Antimicrob Agents Chemother. 2003 Sep;47(9):3021-4. doi: 10.1128/AAC.47.9.3021-3024.2003.
6
Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR.通过定量实时聚合酶链反应评估人类疱疹病毒8对抗病毒药物的敏感性
J Clin Microbiol. 2003 Aug;41(8):3897-900. doi: 10.1128/JCM.41.8.3897-3900.2003.
7
Epstein-Barr virus-recent advances.爱泼斯坦-巴尔病毒——最新进展
Lancet Infect Dis. 2003 Mar;3(3):131-40. doi: 10.1016/s1473-3099(03)00543-7.
8
Biology of Kaposi's sarcoma.卡波西肉瘤的生物学特性
Eur J Cancer. 2001 Jul;37(10):1251-69. doi: 10.1016/s0959-8049(01)00121-6.
9
Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.卡波西肉瘤相关疱疹病毒复制对抗病毒药物的敏感性。对潜在治疗的意义。
J Clin Invest. 1997 May 1;99(9):2082-6. doi: 10.1172/JCI119380.
10
Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.卡波西肉瘤相关疱疹病毒（人类疱疹病毒8型）在培养中的裂解性生长。
Nat Med. 1996 Mar;2(3):342-6. doi: 10.1038/nm0396-342.
Zotero 插件